What Happened?
, -based Kronos Bio Appointed Yasir Al-Wakeel as Chief Financial Officer
About the Company
Kronos Bio is clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription. Our proprietary product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks (TRNs) through which they drive oncogenic activity.
About the Person
Yasir Al-Wakeel is Chief Financial Officer at Kronos Bio. Previously, Yasir held various senior HR leadership roles in the industry.
Info Source
News
Short Profile